Canada Sleep Testing Services Market: By Diagnostic Test Type (Home Sleep Testing, In- lab Sleep Testing(Electroencephalogram, Full Polysomnography, CPAP/BiPAP Titration, Multiple Sleep Latency Test (MSLT), Maintenance of Wakefulness Test (MWT)), By Application (Obstructive Sleep Apnoea, Insomnia, Restless Legs Syndrome, Circadian Rhythm Sleeping Disorders, Narcolepsy, and Rapid Eye Movement (REM) Sleep Disorder), By End User (Hospital, Sleep Centres, and  Home Care Settings)

The Canada Sleep Testing Services market was valued at US$ XX million in 2023 and is projected to reach US$ XX million by 2030, at a CAGR of XX% from 2024 to 2030.

Sleep testing services are diagnostic tests used to assess and diagnose sleep disorders. They monitor several physiological parameters when one is asleep, including the brain waves, heart rate, breathing patterns, and blood oxygen levels. The types of sleep tests include polysomnography (PSG), home sleep tests (HST), and multiple sleep latency tests (MSLT). The market for Canada Sleep Testing Services is slowly rising due to increased awareness of sleep disorders, rising cases of conditions such as obstructive sleep apnea, and advancements in the technology of sleep studies.

Key players

The Sleep Testing Services market share is inclusive of several companies such as RHS Canada, PEAKSleep, Biron Health Group, Dorma Lab, Careica Health and so on.

Key Takeaways

• The fastest-growing region is Asia-Pacific
• Based on diagnostic test type, the home sleep testing segment holds the 29.1% market share
• Based on application, the obstructive sleep apnoea segment holds the 32.4% market share
• Based on the end-use industry, the hospital segment holds a 47.2% market share

Facts & Figures

• About 26% of adults aged 18 and older reported symptoms consistent with sleep apnoea in Canada as of 2022, a main driver for sleep testing services.
• In Canada, as of 2023, the average wait times for publicly funded polysomnography studies are usually six to twelve months because of high demand and the availability of sleep labs is rather poor.
• Almost 40% of sleep tests conducted in Canada were home-based in 2023, which shows a shift towards more lab-based polysomnography to options done at home as more accessible alternatives.

Key Developments

• 2020: Nox Medical Canada Inc. launched its first physical location in Canada, focusing on the distribution of advanced sleep testing equipment and customer support.
• 2023: VirtuOx introduced a new home sleep testing program that leverages digital health tools to provide more accessible and convenient diagnostic services.

Canada Sleep Testing Services Market Segmentation

By Diagnostic Test Type: The Home Sleep Testing segment leads the Canada Sleep Testing Services market. This is mainly because it is more convenient and cost-effective compared to in-lab testing. Home sleep tests are less invasive and more accessible for patients, which is a preferred choice for many. Moreover, the accuracy of home testing devices has improved with technological advancements, further driving their popularity.

By Application: The Obstructive Sleep Apnoea is the segment that leads in the market of Canada Sleep Testing Services. This happens due to the high prevalence of the disorder and also its potential health impact on the human body, causing an upsurge in demand for diagnosis services. This is the most common disorder that is likely to have severe complications if left undiagnosed. The market dominance is characterized by a major emphasis on testing and managing OSA.

By End User: The hospital segment is the largest of the Canada sleep testing services market, as hospitals usually have modern technology, special facilities, and well-trained medical staff. Thus, most patients like to visit hospitals for their complete sleep studies and an accurate diagnosis.